• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养干预非酒精性脂肪性肝病管理的证据回顾。

Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review.

机构信息

Endocrinology Division, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.

Hospital Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona, Spain.

出版信息

Nutrients. 2020 Dec 17;12(12):3860. doi: 10.3390/nu12123860.

DOI:10.3390/nu12123860
PMID:33348700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766941/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is on the rise worldwide representing a public health issue. Its coexistence with obesity and other metabolic alterations is highly frequent. Therefore, current therapy interventions for NAFLD are mainly focused on progressive weight loss through modulation of overall calorie intake with or without specific macronutrient adjustments. Furthermore, other relevant nutritional interventions are built on food selection and time-restricted eating. Since every strategy might bring different results, choosing the optimal diet therapy for a patient is a complicated task, because NAFLD is a multifactorial complex disease. Importantly, some factors need to be considered, such as nutrition-based evidence in terms of hepatic morphophysiological improvements as well as adherence of the patient to the meal plan and adaptability in their cultural context. Thus, the purpose of this review is to explore and compare the subtleties and nuances of the most relevant clinical practice guidelines and the nutritional approaches for the management of NAFLD with a special attention to tangible outcomes and long-term adherence.

摘要

非酒精性脂肪性肝病(NAFLD)在全球范围内呈上升趋势,是一个公共卫生问题。它与肥胖和其他代谢异常的共存率非常高。因此,目前针对 NAFLD 的治疗干预主要集中在通过调节总热量摄入来逐步减轻体重,无论是否进行特定的宏量营养素调整。此外,其他相关的营养干预措施是基于食物选择和限时进食。由于每种策略可能带来不同的结果,因此为患者选择最佳的饮食疗法是一项复杂的任务,因为 NAFLD 是一种多因素的复杂疾病。重要的是,需要考虑一些因素,例如基于肝形态生理学改善的营养证据,以及患者对膳食计划的依从性和在其文化背景下的适应性。因此,本综述的目的是探讨和比较管理 NAFLD 的最相关临床实践指南和营养方法的细微差别和细微差别,特别关注切实的结果和长期依从性。

相似文献

1
Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review.营养干预非酒精性脂肪性肝病管理的证据回顾。
Nutrients. 2020 Dec 17;12(12):3860. doi: 10.3390/nu12123860.
2
Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.超越体重减轻:NAFLD 中靶向肝内脂肪的饮食策略。
Nutrients. 2020 May 6;12(5):1316. doi: 10.3390/nu12051316.
3
Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.饮食组成与非酒精性脂肪性肝病管理中的体重减轻无关。
Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800.
4
Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.限热量的地中海饮食和低脂饮食对非酒精性脂肪肝患者的脂肪酸状态的影响。
Nutrients. 2020 Dec 23;13(1):15. doi: 10.3390/nu13010015.
5
Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者实现体重减轻的营养方法。
Adv Nutr. 2017 Mar 15;8(2):253-265. doi: 10.3945/an.116.013730. Print 2017 Mar.
6
Is there an 'ideal' diet for patients with NAFLD?非酒精性脂肪性肝病患者是否存在“理想”饮食?
Eur J Clin Invest. 2022 Mar;52(3):e13659. doi: 10.1111/eci.13659. Epub 2021 Aug 2.
7
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.生酮饮食对非酒精性脂肪性肝病的有益作用:文献综述。
Obes Rev. 2020 Aug;21(8):e13024. doi: 10.1111/obr.13024. Epub 2020 Mar 24.
8
Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches.非酒精性脂肪性肝病治疗范式的转变:从病理生理学到新型饮食方法。
Nutrients. 2021 Jun 8;13(6):1977. doi: 10.3390/nu13061977.
9
Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe.北欧非酒精性脂肪性肝病患者采用地中海饮食的障碍和促进因素。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1364-1371.e3. doi: 10.1016/j.cgh.2018.10.044. Epub 2018 Oct 31.
10
Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.非酒精性脂肪性肝病治疗饮食方法评估:系统综述。
Nutrients. 2019 Dec 16;11(12):3064. doi: 10.3390/nu11123064.

引用本文的文献

1
Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis.代谢功能障碍相关脂肪性肝病非药物管理的障碍与促进因素:一项定性证据综合分析
Front Pharmacol. 2025 Aug 29;16:1615809. doi: 10.3389/fphar.2025.1615809. eCollection 2025.
2
Analysis of Dietary Behavior and Quality in Children and Adolescents with Non-alcoholic Fatty Liver Disease Using the Korean Nutrition Quotient Score.使用韩国营养商数评分对非酒精性脂肪性肝病儿童和青少年的饮食行为及质量进行分析。
Pediatr Gastroenterol Hepatol Nutr. 2025 Jul;28(4):256-266. doi: 10.5223/pghn.2025.28.4.256. Epub 2025 Jul 7.
3
Targeted therapeutic strategies as alternative and sustainable treatment options for obesity-induced steatohepatitis.靶向治疗策略作为肥胖诱导性脂肪性肝炎的替代和可持续治疗选择。
Rev Endocr Metab Disord. 2025 Jun 25. doi: 10.1007/s11154-025-09980-7.
4
The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes.饮食干预对代谢功能障碍相关脂肪性肝病(MASLD)及合并症(包括肥胖和2型糖尿病)代谢结局的影响
Nutrients. 2025 Apr 3;17(7):1257. doi: 10.3390/nu17071257.
5
Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease-the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression.代谢功能障碍相关脂肪性肝病中的常量营养素调节——脂肪酸与糖类在人体代谢和疾病进展中的分子作用比较
Adv Nutr. 2025 Mar;16(3):100375. doi: 10.1016/j.advnut.2025.100375. Epub 2025 Jan 20.
6
A Very Low-Carbohydrate Program in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease and Phospholipase Domain-Containing Protein 3 Risk Genotype: Pre-Post Intervention Study.针对患有代谢功能障碍相关脂肪性肝病且携带含磷脂酶结构域蛋白3风险基因型的成年人的极低碳水化合物计划:干预前后研究。
JMIR Form Res. 2025 Jan 10;9:e60051. doi: 10.2196/60051.
7
Shear Wave Dispersion Elastography in ALD and MASLD: Comparative Pathophysiology and Clinical Potential-A Narrative Review.成人隐匿性自身免疫性糖尿病和代谢相关脂肪性肝病中的剪切波频散弹性成像:比较病理生理学和临床潜力——一项叙述性综述
J Clin Med. 2024 Dec 20;13(24):7799. doi: 10.3390/jcm13247799.
8
Association between Dietary Quality and Non-Alcoholic Fatty Liver Disease in Korean Adults: A Nationwide, Population-Based Study Using the Korean Healthy Eating Index (2013-2021).韩国成年人饮食质量与非酒精性脂肪肝的相关性:一项使用韩国健康饮食指数(2013-2021 年)的全国性、基于人群的研究。
Nutrients. 2024 May 17;16(10):1516. doi: 10.3390/nu16101516.
9
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.生活方式干预治疗代谢相关脂肪性肝病:24 小时综合行为观点
Hepatol Int. 2024 Oct;18(Suppl 2):959-976. doi: 10.1007/s12072-024-10663-9. Epub 2024 May 8.
10
Nutritional Support for Liver Diseases.肝脏病的营养支持。
Nutrients. 2023 Aug 19;15(16):3640. doi: 10.3390/nu15163640.

本文引用的文献

1
Insights from a general practice service evaluation supporting a lower carbohydrate diet in patients with type 2 diabetes mellitus and prediabetes: a secondary analysis of routine clinic data including HbA1c, weight and prescribing over 6 years.一项支持2型糖尿病和糖尿病前期患者采用低碳水化合物饮食的全科医疗服务评估的见解:对包括糖化血红蛋白、体重及6年用药情况的常规门诊数据的二次分析
BMJ Nutr Prev Health. 2020 Nov 2;3(2):285-294. doi: 10.1136/bmjnph-2020-000072. eCollection 2020 Dec.
2
Liver disease in obesity and underweight: the two sides of the coin. A narrative review.肥胖和消瘦人群中的肝脏疾病:一枚硬币的两面。一篇叙述性综述。
Eat Weight Disord. 2021 Oct;26(7):2097-2107. doi: 10.1007/s40519-020-01060-w. Epub 2020 Nov 4.
3
Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.饱和脂肪与健康:重新评估与基于食物的推荐建议:JACC 现状评价综述。
J Am Coll Cardiol. 2020 Aug 18;76(7):844-857. doi: 10.1016/j.jacc.2020.05.077. Epub 2020 Jun 17.
4
Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations.非酒精性脂肪性肝病患者的地中海饮食:观察性和临床研究的系统评价与荟萃分析
J Diabetes Metab Disord. 2020 Feb 17;19(1):575-584. doi: 10.1007/s40200-019-00475-2. eCollection 2020 Jun.
5
A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic Diet.标准血脂检查对于高脂低碳水化合物生酮饮食患者的护理是不够的。
Front Med (Lausanne). 2020 Apr 15;7:97. doi: 10.3389/fmed.2020.00097. eCollection 2020.
6
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases.地中海饮食营养物助力改善胰岛素抵抗及相关疾病
Nutrients. 2020 Apr 12;12(4):1066. doi: 10.3390/nu12041066.
7
Dietary Factors in Relation to Liver Fat Content: A Cross-sectional Study.饮食因素与肝内脂肪含量的关系:一项横断面研究。
Nutrients. 2020 Mar 20;12(3):825. doi: 10.3390/nu12030825.
8
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.生酮饮食对非酒精性脂肪性肝病的有益作用:文献综述。
Obes Rev. 2020 Aug;21(8):e13024. doi: 10.1111/obr.13024. Epub 2020 Mar 24.
9
Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort.按肝硬化状态划分的饮食质量与非酒精性脂肪性肝病的关联:多民族队列研究
Curr Dev Nutr. 2020 Feb 20;4(3):nzaa024. doi: 10.1093/cdn/nzaa024. eCollection 2020 Mar.
10
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.生酮饮食对非酒精性脂肪性肝病肝脂肪变性和肝线粒体代谢的影响。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7347-7354. doi: 10.1073/pnas.1922344117. Epub 2020 Mar 16.